XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
NOTE 5 – STOCKHOLDERS’ DEFICIT
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
NOTE 5 – STOCKHOLDERS’ DEFICIT

NOTE 5 – STOCKHOLDERS’ DEFICIT

 

The Company is authorized to issue 295,000,000 authorized shares of common stock with a par value of $0.001 as of September 30, 2023 and December 31, 2022. On November 4, 2022, Trustfeed reduced its authorized shares of common stock, par value $0.001 per share, from 1,000,000,000 shares to 295,000,000 shares.  On June 3, 2022, the Board authorized the execution of a reverse split of the issued and outstanding shares of the Corporation’s common stock at a ratio of up to one post-split share per two thousand pre-split shares (1:2,000) at a time and exact ratio amount the Board of Directors deems appropriate. On September 2, 2022, FINRA approved a 1-for-2,000 reverse stock split of the Company’s common stock that was approved by the Company’s Board of Directors. The Company had 109,138,049 and 107,582,614 issued and outstanding shares of common stock as of September 30, 2023 and December 31, 2022, respectively.

 

The Company also has 500,000 authorized shares of preferred stock with a par value of $0.001 of which the Company has designated 500,000 shares as Series A Preferred Stock as of September 30, 2023 and December 31, 2022. On November 4, 2022, Trustfeed reduced its authorized shares of preferred stock, par value $0.001 per share, from 50,000,000 shares to 500,000 shares. Each share of Series A Preferred Stock is convertible, at any time, at the option of the holder into fully paid and nonassessable shares of common stock at the rate of 20 shares of common stock for each share held. In addition, the holders of the Series A Preferred have voting rights equal to 20 votes for each Preferred share held. As of September 30, 2023 and December 31, 2022, 500,000 and 500,000 shares of Series A Preferred stock issued and outstanding.

 

On November 4, 2022, Trustfeed filed Certificates of Withdrawal in Nevada to withdraw the Certificates of Designation for Series B Preferred Stock and Series C Preferred Stock. Following the transaction, the only designated and outstanding shares of preferred. stock are the company’s Series A Preferred Stock. No shares of Series B Preferred stock or Series C Preferred Stock are issued and outstanding.

 

During the nine months ended September 30, 2023 the Company issued 1,555,435 shares of common stock for cash proceeds of $253,236, of which $37,044 had been received in a prior period.